Medeon Biodesign Balance Sheet Health
Financial Health criteria checks 6/6
Medeon Biodesign has a total shareholder equity of NT$1.8B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$2.1B and NT$333.2M respectively.
Key information
0%
Debt to equity ratio
NT$0
Debt
| Interest coverage ratio | n/a |
| Cash | NT$1.38b |
| Equity | NT$1.75b |
| Total liabilities | NT$333.25m |
| Total assets | NT$2.09b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 6499's short term assets (NT$1.5B) exceed its short term liabilities (NT$193.9M).
Long Term Liabilities: 6499's short term assets (NT$1.5B) exceed its long term liabilities (NT$139.3M).
Debt to Equity History and Analysis
Debt Level: 6499 is debt free.
Reducing Debt: 6499 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6499 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 6499 has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 36% each year.